| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.39 | 7e-34 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-17 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-11 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.3 | 2e-09 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-07 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.12 | 4e-05 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.12 | 5e-05 |